bibliographicCitation |
Ebato T, Ogata S, Ogihara Y, Fujimoto M, Kitagawa A, Takanashi M, Ishii M. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease. The Journal of Pediatrics. 2017 Dec;191():140–4. doi: 10.1016/j.jpeds.2017.08.076. |